Life Technologies

Life Technologies Parkinson’s disease cell models—part 3

Issue link: http://life-technologies.uberflip.com/i/368629

Contents of this Issue

Navigation

Page 10 of 33

11 Life Technologies ™ | lifetechnologies.com/parkinsons Figure 2. Workflow for genome editing of iPSCs. (A) Feeder-free iPSCs cultured in Essential 8 ™ Medium and on Geltrex ® matrix–coated plates were treated with thiazovivin before dissociation with StemPro ® Accutase ® Cell Dissociation Reagent. Dissociated cells were electroporated with TAL constructs with or without donor DNA using the Neon ® Transfection System, and then plated at a low density onto MEF or Geltrex ® matrix–coated plates for recovery. After 1 to 2 weeks, colonies were picked, screened, and selected based on results obtained with the GeneArt ® Genomic Cleavage Detection Kit, TaqMan ® SNP Genotyping Assay, or Ion PGM ™ Sequencer. The final clones were expanded and characterized to confirm pluripotency and genomic integrity. (B) Colony screening workflow. Colonies were manually divided in half, with half the cells analyzed and the other half cultured until analysis was complete. PCR amplification of genomic DNA was performed to obtain the sensitivity needed to monitor changes at the target location in the GeneArt ® Genomic Cleavage Detection and PGM assays. These resulting amplicons were then analyzed using the three screening methodologies shown. Note that the sensitivity of the TaqMan ® SNP Genotyping Assays is such that the PCR steps can be omitted if the other methodologies are not used. Treat iPSCs with StemPro ® Accutase ® to dissociate, then transfect with TAL-FokI pairs Plate cells at low density to form well-separated colonies Allow 1–2 weeks for colony expansion, then harvest colonies using pipettor Each colony half is kept for analysis, half is expanded Colonies containing editing events dissociated using Accutase ® reagent, plated at low density, and screening process repeated to isolate a clonal population Harvest cells for analysis Extract genomic DNA Perform 1 st round of PCR amplification Perform 2 nd nested PCR amplification TaqMan ® SNP Genotyping GeneArt ® Genomic Cleavage Detection Ion PGM ™ Sequencing Analysis sub-workflow B Methods Analysis Expansion ★ Analysis Expansion ★

Articles in this issue

Links on this page

view archives of Life Technologies - Life Technologies Parkinson’s disease cell models—part 3